Marivi Mendizabal
GE Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marivi Mendizabal.
Circulation | 2005
Jing Hua; Lawrence W. Dobrucki; Mehran M. Sadeghi; Jiasheng Zhang; Brian N. Bourke; Patti Cavaliere; James Song; Conroy Chow; Neda Jahanshad; Niels van Royen; Ivo R. Buschmann; Joseph A. Madri; Marivi Mendizabal; Albert J. Sinusas
Background—Noninvasive imaging strategies play a critical role in assessment of the efficacy of angiogenesis therapies. The &agr;v&bgr;3 integrin is activated in angiogenic vessels and represents a potential target for noninvasive imaging of angiogenesis. Methods and Results—We evaluated a 99mTc-labeled peptide (NC100692) targeted at &agr;v&bgr;3 integrin for imaging in an established murine model of angiogenesis induced by hindlimb ischemia. Control mice (n=9) or mice with surgical right femoral artery occlusion (n=29) were injected with NC100692 (1.5±0.2 mCi IV) at different times after femoral occlusion (1, 3, 7, and 14 days) for in vivo pinhole planar gamma camera imaging. Tissue from hindlimb proximal and distal to occlusion was excised for gamma well counting and for immunostaining. On in vivo pinhole images, increased focal NC100692 activity was seen distal to the occlusion at days 3 and 7. This increase in relative NC100692 activity was confirmed by gamma well counting. Lectin staining confirmed increased angiogenesis in the ischemic hindlimb at these time points. A fluorescent analogue of NC100692 was used to confirm specificity and localization of the targeted tracer in cultured endothelial cells. In addition, endothelial cell specificity was confirmed on tissue sections with the use of dual immunofluorescent staining of endothelium and the fluorescent analogue targeted at the &agr;v&bgr;3 integrin. Conclusions—A 99mTc-labeled peptide (NC100692) targeted at &agr;v&bgr;3 integrin selectively localized to endothelial cells in regions of increased angiogenesis and could be used for noninvasive serial “hot spot” imaging of angiogenesis. This targeted radiotracer imaging approach is a major advance in tracking therapeutic myocardial angiogenesis and has an important clinical potential.
Journal of Molecular and Cellular Cardiology | 2010
Lawrence W. Dobrucki; Yoshiaki Tsutsumi; Leszek Kalinowski; Jarrod Dean; Mary Gavin; Sabyasachi Sen; Marivi Mendizabal; Albert J. Sinusas; Ryuichi Aikawa
Insulin-like growth factor-1 (IGF-1) has been found to exert favorable effects on angiogenesis in prior animal studies. This study explored the long-term effect of IGF-1 on angiogenesis using microSPECT-CT in infarcted rat hearts after delivering human IGF-1 gene by adeno-associated virus (AAV). Myocardial infarction (MI) was induced in Sprague-Dawley rats by ligation of the proximal anterior coronary artery and a total of 10(11) AAV-CMV-lacZ (control) or IGF-1 vectors were injected around the peri-infarct area. IGF-1 expression by AAV stably transduced heart muscle for up to 16 weeks post-MI and immunohistochemistry revealed a remarkable increase in capillary density. A (99m)Tc-labeled RGD peptide (NC100692, GE Healthcare) was used to assess temporal and regional alpha(v) integrin activation. Rats were injected with NC100692 followed by (201)Tl chloride and in vivo microSPECT-CT imaging was performed. After imaging, hearts were excised and cut for quantitative gamma-well counting (GWC). NC100692 retention was significantly increased in hypoperfused regions of both lacZ and IGF-1 rats at 4 and 16 weeks post-MI. Significantly higher activation of alpha(v) integrin was observed in IGF-1 rats at 4 weeks after treatment compared with control group, although the activation was lower in the IGF-1 group at 16 weeks. Local IGF-1 gene delivery by AAV can render a sustained transduction and improve cardiac function post-MI. IGF-1 expression contributes to enhanced alpha(v) integrin activation which is linked to angiogenesis. MicroSPECT-CT imaging with (99m)Tc-NC100692 and quantitative GWC successfully assessed differences in alpha(v) integrin activation between IGF-1-treated and control animals post-MI.
The Journal of Nuclear Medicine | 2009
Lawrence W. Dobrucki; Donald P. Dione; Leszek Kalinowski; Donna Dione; Marivi Mendizabal; Jun Yu; Xenophon Papademetris; William C. Sessa; Albert J. Sinusas
Previous studies by our group have demonstrated the feasibility of noninvasive imaging of αv integrin to assess temporal and spatial changes in peripheral and myocardial angiogenesis. In this study, we validate the reproducibility, accuracy, and applicability of a new semiautomated noninvasive approach for serial quantitative evaluation of targeted micro-SPECT/CT images of peripheral angiogenesis in wild-type and endothelial nitric oxide sythase (eNOS)–deficient (eNOS−/−) mice subjected to hindlimb ischemia. Methods: Mice (n = 15) underwent surgical ligation of the right femoral artery to induce unilateral hindlimb ischemia. One week after ligation, a 99mTc-labeled cyclic–Arg-Gly-Asp peptide targeted at αv integrin (NC100692, n = 10) or a 99mTc-labeled negative control (AH-111744, n = 5) was injected, and 60 min later in vivo micro-SPECT/CT images were acquired. Mice were euthanized, tissue from proximal and distal hindlimb was excised for γ-well counting (GWC) of radiotracer activity, and ischemic-to-nonischemic (I/NI) ratio was calculated. Micro-SPECT/CT images were analyzed using a new semiautomated approach that applies complex volumes of interest (VOIs) derived from segmentation of the micro-CT images onto micro-SPECT images to calculate I/NI activity ratios for the proximal and distal hindlimb. Studies were reprocessed for determination of intra- and interobserver variability. To compare 3-dimensional (3D) VOI analysis with traditional manual 2-dimensional region-of-interest (ROI) analysis of maximum-intensity-projection images, micro-SPECT images were summed onto a single anterior–posterior projection. Rectangular ROIs were manually drawn and I/NI ratio calculated. Our new 3D analysis approach was applied to additional groups of mice (eNOS−/−, n = 5; wild-type, n = 3) imaged before and 1 and 4 wk after femoral artery resection. Results: Our new semiautomated approach for the evaluation of images of αv integrin targeted with micro-SPECT/CT demonstrated both a high intra- and interobserver variability (R2 = 0.997) and an accuracy (R2 = 0.780) for estimation of relative radiotracer activity relative to GWC. Analysis of serial micro-SPECT/CT images demonstrated a significant increase in relative NC100692 retention in the ischemic hindlimb of both wild-type and eNOS−/− mice at 1 wk after surgery. There was a significant (∼25%) decrease in radiotracer uptake in eNOS−/− mice relative to wild-type animals, which was not observed at baseline or 4 wk after ligation. Conclusion: A new semiautomated analysis of images of αv integrin targeted with micro-SPECT/CT provides a noninvasive approach for serial quantitative evaluation of peripheral angiogenesis. The reproducibility and accuracy of this approach allows for quantitative analysis of serial targeted molecular images of lower extremities, has applicability to other targeted SPECT or PET radiotracers, and may have implications for clinical imaging in patients with peripheral arterial disease.
The Journal of Nuclear Medicine | 2002
Henry R. Wolfe; Marivi Mendizabal; Elinor Lleong; Alan Cuthbertson; Vinay Chandrakant Desai; Shirley Pullan; Dennis Kiyoshi Fujii; Matthew Morrison; Richard Pither; Scott A. Waldman
Bioorganic & Medicinal Chemistry Letters | 2006
Bård Indrevoll; Grete Mørk Kindberg; Magne Solbakken; Emma Bjurgert; John Henrik Johansen; Hege Karlsen; Marivi Mendizabal; Alan Cuthbertson
Archive | 2004
Anthony Eamon Storey; Julie Davis; Sally-Ann Ricketts; Marivi Mendizabal; Alan Cuthbertson; Joseph Arukwe; Kirsty Heywood; Ian Wilson; Duncan Wynn; Michael Schafers; Bodo Levkau; Stefan Wagner; Hans-Jörg Breyholz; Klaus Kopka
Archive | 1997
Karen Jane Barnes; Gary Robert Bower; Alan M. Forster; Peter Knox; Marivi Mendizabal; Anthony Eamon Storey
Archive | 1999
Anthony Eamon Storey; Marivi Mendizabal; Susan Champion; Alex Gibson; Benedicte Guilbert; Ian Wilson; Peter Knox
Archive | 2002
Alan Cuthbertson; Marivi Mendizabal; Mark Dixon; Anthony Eamon Storey
Journal of Labelled Compounds and Radiopharmaceuticals | 2007
Richard A. Frank; Bengt Långström; Gunnar Antoni; Michael Christopher Montalto; Eric D. Agdeppa; Marivi Mendizabal; Ian Wilson; Jean-Luc Vanderheyden